How severe is CVE-2025-33136?

CVE-2025-33136 has a CVSS 3.x base score of 7.1, rated high severity. It is exploitable over network with low attack complexity, requires low privileges and no user interaction. Impact on confidentiality is high, integrity low, and availability none.

Is CVE-2025-33136 being actively exploited?

It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 0% (21st percentile), an estimate of the probability of exploitation in the next 30 days.

What products are affected by CVE-2025-33136?

CVE-2025-33136 affects Ibm Aspera Faspex. See the affected-products list for the exact vulnerable versions.

How do I fix CVE-2025-33136?

Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround. Given its high severity, prioritise patching exposed systems.

Does CVE-2025-33136 have an EU (EUVD) identifier?

Yes. CVE-2025-33136 is tracked in the ENISA EU Vulnerability Database (EUVD) as EUVD-2025-16173.

When was CVE-2025-33136 published?

CVE-2025-33136 was published on 2025-05-22 and last updated on 2026-06-17.

CVE-2025-33136

CVE-2025-33136 is a high-severity vulnerability in Ibm Aspera Faspex with a CVSS 3.x base score of 7.1. It is not currently listed as actively exploited by CISA, and its EPSS exploit-prediction score is low. The underlying weakness is classified as CWE-471.

Key facts

Severity: High (CVSS 3.x base score 7.1)
EPSS exploit prediction: 0% (21st percentile)
Actively exploited: Not listed in CISA KEV
EU (EUVD) id: EUVD-2025-16173
Weakness: CWE-471
Affected product: Ibm Aspera Faspex
Published: 2025-05-22
Last modified: 2026-06-17

Description

IBM Aspera Faspex 5.0.0 through 5.0.12 could allow an authenticated user to obtain sensitive information or perform unauthorized actions on behalf of another user due to improper protection of assumed immutable data.

Frequently asked questions

What is CVE-2025-33136?: IBM Aspera Faspex 5.0.0 through 5.0.12 could allow an authenticated user to obtain sensitive information or perform unauthorized actions on behalf of another user due to improper protection of assumed immutable data.
How severe is CVE-2025-33136?: CVE-2025-33136 has a CVSS 3.x base score of 7.1, rated high severity. It is exploitable over network with low attack complexity, requires low privileges and no user interaction. Impact on confidentiality is high, integrity low, and availability none.
Is CVE-2025-33136 being actively exploited?: It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 0% (21st percentile), an estimate of the probability of exploitation in the next 30 days.
What products are affected by CVE-2025-33136?: CVE-2025-33136 affects Ibm Aspera Faspex. See the affected-products list for the exact vulnerable versions.
How do I fix CVE-2025-33136?: Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround. Given its high severity, prioritise patching exposed systems.
Does CVE-2025-33136 have an EU (EUVD) identifier?: Yes. CVE-2025-33136 is tracked in the ENISA EU Vulnerability Database (EUVD) as EUVD-2025-16173.
When was CVE-2025-33136 published?: CVE-2025-33136 was published on 2025-05-22 and last updated on 2026-06-17.

References

https://www.ibm.com/support/pages/node/7234114

Affected products (1)

cpe:2.3:a:ibm:aspera_faspex:*:*:*:*:*:*:*:*

More vulnerabilities in Ibm Aspera Faspex

CVE-2023-27874 — Critical (CVSS 9.9): IBM Aspera Faspex 4.4.2 is vulnerable to an XML external entity injection (XXE) attack when processing XML data. A…
CVE-2022-47986 — Critical (CVSS 9.8): IBM Aspera Faspex 4.4.2 Patch Level 1 and earlier could allow a remote attacker to execute arbitrary code on the…
CVE-2023-37400 — High (CVSS 7.8): IBM Aspera Faspex 5.0.0 through 5.0.7 could allow a local user to escalate their privileges due to insecure credential…
CVE-2023-30995 — High (CVSS 7.5): IBM Aspera Faspex 4.0 through 4.4.2 and 5.0 through 5.0.5 could allow a malicious actor to bypass IP whitelist…
CVE-2023-27871 — High (CVSS 7.5): IBM Aspera Faspex 4.4.2 could allow a remote attacker to obtain sensitive credential information for an external user,…
CVE-2023-27875 — High (CVSS 7.5): IBM Aspera Faspex 5.0.4 could allow a user to change other user's credentials due to improper access controls. IBM…

All CVEs affecting Ibm Aspera Faspex →

Other CWE-471 vulnerabilities

CVE-2022-25893 — Critical (CVSS 9.8): The package vm2 before 3.9.10 are vulnerable to Arbitrary Code Execution due to the usage of prototype lookup for the…
CVE-2018-3722 — High (CVSS 8.8): merge-deep node module before 3.0.1 suffers from a Modification of Assumed-Immutable Data (MAID) vulnerability, which…
CVE-2018-3720 — High (CVSS 8.8): assign-deep node module before 0.4.7 suffers from a Modification of Assumed-Immutable Data (MAID) vulnerability, which…
CVE-2018-3728 — High (CVSS 8.8): hoek node module before 4.2.0 and 5.0.x before 5.0.3 suffers from a Modification of Assumed-Immutable Data (MAID)…
CVE-2024-55551 — High (CVSS 8.3): An issue was discovered in Exasol JDBC driver before 24.2.1 (2024-12-10). Attackers can inject malicious parameters…
CVE-2024-9876 — High (CVSS 7.3): : Modification of Assumed-Immutable Data (MAID) vulnerability in ABB ANC, ABB ANC-L, ABB ANC-mini.This issue affects…

Browse all CWE-471 vulnerabilities →